The Volt pulsed-field ablation (PFA) system (Abbott) has been approved by the US Food and Drug Administration for the treatment of patients with atrial fibrillation (AF), according to a Monday ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

Grievances for each local NY team first appeared on Elite Sports NY, the Voice, the Pulse of New York City sports.

ICE detainee dies after emergency call at Adams County CoreCivic facility, raising questions about medical response and care ...

The group’s biggest claims were largely incorrect, a New York Times analysis found. And its many smaller cuts added up to few ...

In today’s Pharma Pulse, Samsung Biologics enters the US market with a $280 million site acquisition, AstraZeneca secures a ...

The Morning Bull - US Market Morning Update Tuesday, Dec, 23 2025 US stock futures are essentially flat this morning, with E mini S&P 500 contracts hovering just below unchanged as investors weigh ...

The Alabama Crimson Tide could be landing one of the top 2027 recruits in the nation in the not-too-distant future. On3's ...

With rising costs, labor shortages, and tighter regulatory scrutiny reshaping property preservation, AREMCO SVP Clellan Kane ...

The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...

Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with ...

Automation technology suppliers are integrating robot kinematics directly into PLCs, simplifying programming, reducing costs, ...